SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Propanc Biopharma to start Phase 1b first-in-human PRP study in Feb 2027

Propanc Biopharma said it will initiate a Phase 1b first-in-human study of PRP in February 2027.

PPCB

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.